<DOC>
	<DOC>NCT00978575</DOC>
	<brief_summary>The trial is a double-blind randomized trial designed to examine whether compliant iron therapy (intravenous or oral) for 3 months after discharge increases hemoglobin levels more and faster than no treatment - in patients with acute bleeding from upper gastrointestinal tract. The trial will include 126 patients at Aarhus University Hospital. In addition to efficacy assessment quality of life assessment and health economic calculations between the treatments will be compared.</brief_summary>
	<brief_title>Iron Substitution After Upper Gastro-Intestinal Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Acute upper gastrointestinal bleeding Anemia Liver disease Terminal cancer Kidney disease variceal bleeding Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Iron treatment</keyword>
	<keyword>Upper gastrointestinal bleeding</keyword>
</DOC>